Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gina Kruse

Concepts (221)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
16
2024
407
5.700
 Why?
Text Messaging
5
2023
149
2.490
 Why?
Smoking
8
2023
1459
1.760
 Why?
Early Detection of Cancer
6
2025
369
1.520
 Why?
Primary Health Care
7
2023
1639
1.370
 Why?
Tobacco Use
3
2022
61
1.130
 Why?
Smokers
4
2020
137
1.090
 Why?
Colorectal Neoplasms
4
2025
746
1.050
 Why?
Tobacco Use Cessation
2
2024
24
0.970
 Why?
Tobacco Use Disorder
3
2022
237
0.960
 Why?
Buprenorphine
2
2025
160
0.860
 Why?
Uterine Cervical Neoplasms
2
2024
232
0.860
 Why?
Postal Service
2
2020
32
0.860
 Why?
Massachusetts
7
2025
158
0.810
 Why?
Community Health Services
2
2015
226
0.770
 Why?
Laboratories
1
2023
109
0.770
 Why?
Electronic Nicotine Delivery Systems
4
2022
88
0.730
 Why?
United States Indian Health Service
2
2022
42
0.720
 Why?
Patient Discharge
3
2024
850
0.700
 Why?
Mentoring
1
2023
130
0.680
 Why?
Electronic Health Records
4
2016
973
0.670
 Why?
Alaska Natives
1
2022
137
0.640
 Why?
Papillomavirus Infections
1
2023
290
0.630
 Why?
Tobacco Products
1
2020
110
0.620
 Why?
Health Behavior
3
2022
740
0.600
 Why?
Delivery of Health Care
4
2023
888
0.580
 Why?
Community Health Centers
5
2025
57
0.570
 Why?
Rural Population
3
2024
511
0.560
 Why?
Humans
54
2025
128019
0.550
 Why?
Meaningful Use
1
2016
13
0.530
 Why?
Middle Aged
22
2025
30812
0.520
 Why?
Indians, North American
1
2022
599
0.510
 Why?
Comorbidity
2
2017
1537
0.480
 Why?
HIV Infections
7
2024
2703
0.480
 Why?
Motivation
2
2019
544
0.480
 Why?
Female
33
2025
68016
0.460
 Why?
Smoke-Free Policy
1
2014
13
0.460
 Why?
Opiate Substitution Treatment
3
2025
134
0.460
 Why?
Smoking Prevention
1
2015
161
0.450
 Why?
Telemedicine
2
2021
781
0.450
 Why?
Unnecessary Procedures
1
2014
48
0.450
 Why?
Male
29
2025
62757
0.440
 Why?
Adult
25
2025
35176
0.430
 Why?
Tobacco Smoking
2
2024
25
0.420
 Why?
Pilot Projects
5
2022
1559
0.420
 Why?
Reimbursement, Incentive
1
2013
36
0.420
 Why?
Program Development
1
2015
357
0.410
 Why?
Counseling
4
2024
382
0.410
 Why?
Health Equity
3
2024
82
0.390
 Why?
Colonoscopy
1
2014
234
0.390
 Why?
Tobacco Smoke Pollution
1
2014
229
0.370
 Why?
Documentation
1
2013
181
0.370
 Why?
Population Surveillance
1
2014
426
0.370
 Why?
Neoplasms
2
2023
2460
0.370
 Why?
Telephone
2
2023
165
0.370
 Why?
Anti-HIV Agents
2
2014
749
0.330
 Why?
Hospitalization
2
2021
2057
0.330
 Why?
Cross-Sectional Studies
8
2024
5034
0.310
 Why?
Referral and Consultation
2
2012
724
0.300
 Why?
Aged
12
2025
21892
0.280
 Why?
Opioid-Related Disorders
2
2025
480
0.270
 Why?
Students
2
2022
570
0.270
 Why?
Boston
3
2024
86
0.250
 Why?
United States
7
2024
13785
0.250
 Why?
South Africa
2
2024
192
0.250
 Why?
Feasibility Studies
2
2022
860
0.240
 Why?
Appointments and Schedules
2
2002
81
0.230
 Why?
Pandemics
3
2021
1473
0.230
 Why?
Occult Blood
1
2024
30
0.220
 Why?
Faculty
2
2022
135
0.220
 Why?
India
2
2024
170
0.220
 Why?
Patient Compliance
2
2012
558
0.220
 Why?
Outpatients
2
2024
366
0.220
 Why?
Mental Disorders
2
2002
1005
0.220
 Why?
Social Determinants of Health
2
2024
220
0.220
 Why?
Narcotic Antagonists
1
2025
160
0.210
 Why?
Vaginal Smears
1
2023
56
0.200
 Why?
Safety-net Providers
1
2024
108
0.200
 Why?
Mass Screening
3
2025
1145
0.200
 Why?
Papillomaviridae
1
2023
113
0.200
 Why?
Interrupted Time Series Analysis
1
2022
53
0.190
 Why?
Outpatient Clinics, Hospital
1
2002
82
0.190
 Why?
Medically Underserved Area
1
2022
83
0.190
 Why?
Treatment Refusal
1
2002
87
0.190
 Why?
Pain Management
1
2005
317
0.190
 Why?
Behavior Therapy
2
2022
236
0.190
 Why?
Student Run Clinic
1
2021
3
0.190
 Why?
Tuberculosis
1
2024
271
0.180
 Why?
Vaping
1
2022
53
0.180
 Why?
Patient Participation
1
2005
409
0.180
 Why?
Ambulatory Care
1
2024
500
0.170
 Why?
Education, Medical, Undergraduate
1
2023
176
0.170
 Why?
Developing Countries
2
2015
285
0.170
 Why?
Interviews as Topic
3
2019
714
0.170
 Why?
Longitudinal Studies
2
2020
2706
0.170
 Why?
Physician-Patient Relations
1
2005
529
0.170
 Why?
Medication Adherence
1
2025
559
0.170
 Why?
Community Networks
1
2020
55
0.170
 Why?
Education, Medical
1
2023
243
0.160
 Why?
Crisis Intervention
1
2019
33
0.160
 Why?
Analgesics, Opioid
2
2024
886
0.160
 Why?
Pain
1
2005
748
0.160
 Why?
Preventive Health Services
1
2020
145
0.150
 Why?
Cohort Studies
5
2025
5378
0.150
 Why?
Students, Medical
1
2023
315
0.150
 Why?
Nevirapine
2
2008
16
0.150
 Why?
Decision Making
1
2005
846
0.140
 Why?
Surveys and Questionnaires
4
2019
5353
0.140
 Why?
Organophosphonates
2
2008
92
0.140
 Why?
Randomized Controlled Trials as Topic
2
2022
1356
0.140
 Why?
Communication
1
2023
838
0.140
 Why?
Deoxycytidine
2
2008
163
0.140
 Why?
Caregivers
1
2024
810
0.130
 Why?
Prevalence
3
2024
2541
0.130
 Why?
Liver Transplantation
1
2024
799
0.130
 Why?
Pneumonia, Viral
1
2021
337
0.130
 Why?
Infectious Disease Transmission, Vertical
2
2008
170
0.130
 Why?
Texas
4
2005
227
0.130
 Why?
Diabetes Mellitus
1
2024
994
0.130
 Why?
Young Adult
5
2024
12281
0.130
 Why?
Adenine
2
2008
255
0.130
 Why?
Diffusion of Innovation
1
2016
96
0.120
 Why?
Focus Groups
2
2022
452
0.120
 Why?
Hypertension
1
2024
1234
0.120
 Why?
Qualitative Research
2
2019
1224
0.120
 Why?
Adolescent
7
2024
20158
0.120
 Why?
Allied Health Personnel
1
2015
40
0.120
 Why?
Community Health Workers
1
2015
50
0.120
 Why?
Health Surveys
1
2017
491
0.120
 Why?
Automobiles
1
2014
19
0.120
 Why?
Logistic Models
3
2017
1975
0.110
 Why?
Uganda
1
2014
72
0.110
 Why?
Residence Characteristics
2
2014
324
0.100
 Why?
Odds Ratio
3
2008
1018
0.100
 Why?
Colonic Polyps
1
2014
87
0.100
 Why?
Program Evaluation
2
2020
872
0.100
 Why?
Patient Admission
1
2014
182
0.100
 Why?
Health Services Accessibility
4
2024
895
0.100
 Why?
Research Design
1
2019
1034
0.100
 Why?
Stress, Psychological
1
2021
1060
0.100
 Why?
Managed Care Programs
1
2013
133
0.100
 Why?
Prospective Studies
3
2025
7035
0.100
 Why?
Hospitals, Psychiatric
2
2002
23
0.100
 Why?
Patient Acceptance of Health Care
3
2022
756
0.100
 Why?
Social Class
1
2014
258
0.100
 Why?
HIV-1
2
2008
833
0.100
 Why?
Nurses
1
2014
164
0.100
 Why?
Feedback
1
2012
159
0.090
 Why?
Emergency Service, Hospital
1
2022
1896
0.090
 Why?
Health Plan Implementation
1
2012
137
0.090
 Why?
Follow-Up Studies
2
2024
4853
0.090
 Why?
Quality Assurance, Health Care
1
2013
315
0.090
 Why?
Hospitals
1
2014
631
0.080
 Why?
Retrospective Studies
4
2022
14404
0.080
 Why?
Diabetes Mellitus, Type 2
1
2022
2428
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
82
0.070
 Why?
Chronic Disease
1
2013
1690
0.070
 Why?
Patient Care Team
1
2012
597
0.070
 Why?
Drug Resistance, Viral
1
2007
110
0.070
 Why?
Renal Insufficiency
1
2008
148
0.070
 Why?
Anti-Retroviral Agents
1
2008
230
0.060
 Why?
Aged, 80 and over
4
2024
7029
0.060
 Why?
Risk Factors
2
2014
9696
0.060
 Why?
Insurance, Health
2
2005
267
0.060
 Why?
Regression Analysis
2
2005
978
0.060
 Why?
Quality Improvement
1
2012
1093
0.060
 Why?
Pregnancy Complications, Infectious
1
2008
363
0.060
 Why?
Insurance Coverage
2
2022
219
0.060
 Why?
Vaccination
2
2022
1343
0.060
 Why?
Drug Therapy, Combination
2
2022
1012
0.050
 Why?
Rural Health Services
1
2004
110
0.050
 Why?
Housing
1
2024
130
0.050
 Why?
Social Networking
1
2023
32
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2022
62
0.050
 Why?
Health Status
2
2005
747
0.050
 Why?
Mobile Health Units
1
2022
19
0.050
 Why?
Midwestern United States
1
2002
41
0.050
 Why?
Health Services for the Aged
1
2003
72
0.050
 Why?
Hospitals, University
1
2002
176
0.050
 Why?
Quality of Life
2
2022
2672
0.050
 Why?
Bupropion
1
2022
40
0.050
 Why?
Varenicline
1
2022
26
0.050
 Why?
Schools, Medical
1
2023
130
0.050
 Why?
Antiviral Agents
1
2007
710
0.050
 Why?
Stakeholder Participation
1
2022
77
0.050
 Why?
England
1
2021
72
0.050
 Why?
Continuity of Patient Care
1
2004
275
0.050
 Why?
Vulnerable Populations
1
2022
157
0.050
 Why?
Meals
1
2022
118
0.050
 Why?
HIV
1
2022
225
0.050
 Why?
Data Collection
1
2024
645
0.040
 Why?
Minority Groups
1
2022
250
0.040
 Why?
Poverty
1
2024
497
0.040
 Why?
Urban Population
1
2003
440
0.040
 Why?
Triage
1
2021
205
0.040
 Why?
Learning
1
2023
393
0.040
 Why?
Medicaid
1
2003
433
0.040
 Why?
Zambia
2
2008
55
0.040
 Why?
Treatment Outcome
1
2012
10110
0.040
 Why?
Medicare
1
2003
715
0.030
 Why?
Practice Guidelines as Topic
1
2025
1482
0.030
 Why?
Emtricitabine
2
2008
168
0.030
 Why?
Tenofovir
2
2008
231
0.030
 Why?
Curriculum
1
2023
909
0.030
 Why?
Child
2
2024
20636
0.020
 Why?
Case-Control Studies
1
2017
3324
0.020
 Why?
Socioeconomic Factors
2
2004
1211
0.020
 Why?
Chi-Square Distribution
1
2008
511
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2008
265
0.020
 Why?
Creatinine
1
2008
478
0.020
 Why?
Risk
1
2008
850
0.020
 Why?
Pregnancy
2
2008
6355
0.020
 Why?
Proportional Hazards Models
1
2008
1194
0.020
 Why?
Glomerular Filtration Rate
1
2008
682
0.010
 Why?
Health Status Indicators
1
2004
166
0.010
 Why?
Office Visits
1
2003
81
0.010
 Why?
Disease Progression
1
2008
2598
0.010
 Why?
Health Care Surveys
1
2003
556
0.010
 Why?
Biomarkers
1
2008
3874
0.010
 Why?
Infant, Newborn
1
2007
5688
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2004
1272
0.010
 Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (221) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)